The Role of Interleukin-18 in Renal Injury

Journal of Surgical Research

Volumn 145, Issue 1, 2008, Pages 170-175

  Leslie, Jeffrey A ^a   Meldrum, Kirstan K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; interleukin 18; ischemia; rejection; renal injury; reperfusion; transplantation

Indexed keywords

CISPLATIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 18; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENDOTOXEMIA; GRAFT REJECTION; HUMAN; ISCHEMIA; KIDNEY INJURY; KUPFFER CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; NATURAL KILLER CELL; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; T LYMPHOCYTE;

ANIMALS; CYSTEINE ENDOPEPTIDASES; ENDOTOXEMIA; GRAFT REJECTION; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; KIDNEY DISEASES; NEPHRITIS; REPERFUSION INJURY;

EID: 38949157739     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.03.037     Document Type: Article

References (44)

1. Dinarello C.A. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103 1 Pt 1 (1999) 11
2. Gu Y., Kuida K., Tsutsui H., et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275 (1997) 206
3. Ghayur T., Banerjee S., Hugunin M., et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386 (1997) 619
4. Rothe H., Jenkins N.A., Copeland N.G., et al. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 99 (1997) 469
5. Wildbaum G., Youssef S., Grabie N., et al. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J Immunol 161 (1998) 6368
6. Esfandiari E., McInnes I.B., Lindop G., et al. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol 167 (2001) 5338
7. Faust J., Menke J., Kriegsmann J., et al. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum 46 (2002) 3083
8. Kohno K., and Kurimoto M. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol 86 (1998) 11
9. Trinchieri G., and Gerosa F. Immunoregulation by interleukin-12. J Leukoc Biol 59 (1996) 505
10. Dinarello C.A., Novick D., Puren A.J., et al. Overview of interleukin-18: More than an interferon-gamma inducing factor. J Leukoc Biol 63 (1998) 658
11. Fantuzzi G., Reed D.A., and Dinarello C.A. IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest 104 (1999) 761
12. Okamura H., Tsutsi H., Komatsu T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88
13. Tsutsui H., Matsui K., Kawada N., et al. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 159 (1997) 3961
14. Shibata M., Hirota M., and Ogawa M. Hepatic injury induced by interleukin-18 administration: Importance of preceding priming effect. J Immunother 25 Suppl 1 (2002) S72
15. Micallef M.J., Ohtsuki T., Kohno K., et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 26 (1996) 1647
16. Yoshimoto T., Okamura H., Tagawa Y.I., et al. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 94 (1997) 3948
17. Ahn H.J., Maruo S., Tomura M., et al. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-gamma. J Immunol 159 (1997) 2125
18. Garcia G.E., Xia Y., Ku G., et al. IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis. Kidney Int 64 (2003) 160
19. Tone M., Thompson S.A., Tone Y., et al. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol 159 (1997) 6156
20. Daemen M.A., van't Veer C., Wolfs T.G., et al. Ischemia/reperfusion-induced IFN-γ up-regulation: Involvement of IL-12 and IL-18. J Immunol 162 (1999) 5506
21. Bohn E., Sing A., Zumbihl R., et al. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 160 (1998) 299
22. Daemen M.A., Denecker G., van't Veer C., et al. Activated caspase-1 is not a central mediator of inflammation in the course of ischemia-reperfusion. Transplantation 71 (2001) 778
23. Melnikov V.Y., Ecder T., Fantuzzi G., et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107 (2001) 1145
24. Melnikov V.Y., Faubel S., Siegmund B., et al. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 110 (2002) 1083
25. Parikh C.R., Jani A., Melnikov V.Y., et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 43 (2004) 405
26. Parikh C.R., Jani A., Mishra J., et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 6 (2006) 1639
27. Striz I., Krasna E., Honsova E., et al. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett 99 (2005) 30
28. Parikh C.R., Abraham E., Ancukiewicz M., et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16 (2005) 3046
29. Wyburn K., Wu H., Yin J., et al. Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrol Dial Transplant 20 (2005) 699
30. Wyburn K., Wu H., Chen G., et al. Interleukin-18 affects local cytokine expression but does not impact on the development of kidney allograft rejection. Am J Transplant 6 (2006) 2612
31. Kitching A.R., Tipping P.G., Kurimoto M., et al. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: Studies in cell-mediated crescentic glomerulonephritis. J Immunol 165 (2000) 4649
32. Arai N., Akamatsu S., Arai S., et al. Interleukin-18 in combination with IL-2 enhances natural killer cell activity without inducing large amounts of IFN-gamma in vivo. J Interferon Cytokine Res 20 (2000) 217
33. Huang F.P., Xu D., Esfandiari E.O., et al. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J Immunol 160 (1998) 4143
34. Kim Y.M., Talanian R.V., Li J., et al. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1β-converting enzyme). J Immunol 161 (1998) 4122
35. Li P., Allen H., Banerjee S., et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80 (1995) 401
36. Li P., Allen H., Banerjee S., and Seshadri T. Characterization of mice deficient in interleukin-1 beta converting enzyme. J. Cell Biochem 64 (1997) 27
37. Fantuzzi G., Zheng H., Faggioni R., et al. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157 (1996) 291
38. Netea M.G., Fantuzzi G., Kullberg B.J., et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol 164 (2000) 2644
39. Wang W., Faubel S., Ljubanovic D., et al. Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice. Am J Physiol Renal Physiol 288 (2005) F997
40. Faubel S., Ljubanovic D., Reznikov L., et al. Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int 66 (2004) 2202
41. Taniguchi M.N.K., Kunikata T., Kayano T., et al. Characterization of anti-human interleukin-18 (IL-18)/interferon inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 ELISA. J Immunol Meth 206 (1997) 107
42. Emmanuilidis K., Weighardt H., Matevossian E., et al. Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: High serum IL-18 as an early predictive indicator of lethal outcome. Shock 18 (2002) 301
43. Ludwiczek O., Kaser A., Novick D., et al. Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 22 (2002) 331
44. Mallat Z., Henry P., Fressonnet R., et al. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 88 (2002) 467